Class effect for sodium glucose-cotransporter-2 inhibitors in cardiovascular outcomes: implications for the cardiovascular disease specialist

Bethel, M. A. and McMurray, J. J.V. (2018) Class effect for sodium glucose-cotransporter-2 inhibitors in cardiovascular outcomes: implications for the cardiovascular disease specialist. Circulation, 137(12), pp. 1218-1220. (doi:10.1161/CIRCULATIONAHA.117.030117) (PMID:29555706)

Full text not currently available from Enlighten.

Abstract

No abstract available.

Item Type:Articles
Keywords:SGLT-2 inhibitor, canagliflozin, cardiovascular diseases, diabetes mellitus, empagliflozin, mortality, myocardial infarction
Status:Published
Refereed:Yes
Glasgow Author(s) Enlighten ID:McMurray, Professor John
Authors: Bethel, M. A., and McMurray, J. J.V.
College/School:College of Medical Veterinary and Life Sciences > Institute of Cardiovascular and Medical Sciences
Journal Name:Circulation
Publisher:American Heart Association
ISSN:0009-7322
ISSN (Online):1524-4539
Published Online:19 March 2018

University Staff: Request a correction | Enlighten Editors: Update this record